Cargando…
Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
BACKGROUND. Many kidney transplant centers in the United States report both HLA class I and II antibodies detected by sensitive solid-phase assays (SPAs) to United Network for Organ Sharing as unacceptable antigens, significantly reducing the compatible donor organ pool and prolonging waiting time f...
Autores principales: | Uffing, Audrey, Hidalgo, Luis G., McMullan, Ciaran, Perry, Jacqueline, Milford, Edgar L., Murakami, Naoka, Yeung, Melissa Y., Guleria, Indira, Wood, Isabelle G., Akalin, Enver, Azzi, Jamil, Chandraker, Anil K., Riella, Leonardo V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511444/ https://www.ncbi.nlm.nih.gov/pubmed/31165081 http://dx.doi.org/10.1097/TXD.0000000000000893 |
Ejemplares similares
-
Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018) -
Comparing Emotional Adjustment of Living-donor and Deceased-donor Kidney Transplant Patients
por: Lai, Yousheng Lester, et al.
Publicado: (2020) -
Time to Move on: HLA Matching Should Be Reconsidered in Modern Deceased Donor Kidney Allocation
por: Gramlick, Madelyn E., et al.
Publicado: (2022) -
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation
por: Krishnan, Nithya, et al.
Publicado: (2021) -
Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing
por: Kalluri, Hari V., et al.
Publicado: (2020)